Company page

Hvivo Plc

Hvivo Plc is a public company listed on the UK market under the ticker HVO, with a market capitalization of approximately £61.4 million. The company specializes in the development and commercialization of innovative solutions for infectious diseases. Hvivo focuses on advancing its proprietary technologies and conducting clinical trials to support its product pipeline.

HVO:LSEUpdated August 21, 2026
Hvivo Plc logo
Ticker
HVO:LSE
Asset type
Stock
Market cap
$61.9M
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
LSE
Currency
GBX